Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells

Parasite Immunology

Volumn 34, Issue 10, 2012, Pages 464-472

  Donovan, M J ^b   Tripathi, V ^c   Favila, M A ^a   Geraci, N S ^a   Lange, M C ^a   Ballhorn, W ^d   Mcdowell, M A ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b Polsinelli Shughart PC   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Dendritic cell; Indoleamine 2,3 dioxygenase; Leishmania

Indexed keywords

1 METHYL TRYPTOPHAN; ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; MESSENGER RNA; TETANUS TOXOID; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CELL LYSATE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; GENE CONTROL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS; PARACRINE SIGNALING; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LYMPHOCYTES;

LEISHMANIA DONOVANI; LEISHMANIA MAJOR;

EID: 84866154034     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2012.01380.x     Document Type: Article

References (53)

1. Maizels R. Regulation of the immune system in metazoan parasite infections. Novartis Found Symp 2007; 281: 192-204; discussion -9.
2. Sacks D & Sher A. Evasion of innate immunity by parasitic protozoa. Nat Immunol 2002; 3: 1041-1047.
3. McDowell MA & Sacks DL. Inhibition of host cell signal transduction by Leishmania: observations relevant to the selective impairment of IL-12 responses. Curr Opin Microbiol 1999; 2: 438-443.
4. Peters N & Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 2006; 213: 159-179.
5. Choi CM & Lerner EA. Leishmaniasis as an emerging infection. J Investig Dermatol Symp Proc 2001; 6: 175-182.
6. Antinori S, Schifanella L & Corbellino M. Leishmaniasis: new insights from an old and neglected disease. Eur J Clin Microbiol Infect Dis 2011; 31: 109-118.
7. Kaye P & Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 2011; 9: 604-615.
8. Liese J, Schleicher U & Bogdan C. The innate immune response against Leishmania parasites. Immunobiology 2008; 213: 377-387.
9. Mougneau E, Bihl F & Glaichenhaus N. Cell biology and immunology of Leishmania. Immunol Rev 2011; 240: 286-296.
10. Pearson DD & Wilson ME. Host defenses against prototypical intracellular protozoans, the Leishmania. In: Genta PDWRM, (ed): Parasitic Infections in the Compromised Host. New York and Basel, Marcel Dekker, Inc., 1989: 31-81.
11. Gantt KR, Schultz-Cherry S, Rodriguez N, et al. Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages. J Immunol 2003; 170: 2613-2620.
12. Passwell JH, Shor R, Smolen J & Jaffe CL. Infection of human monocytes by Leishmania results in a defective oxidative burst. Int J Exp Pathol 1994; 75: 277-284.
13. Lodge R & Descoteaux A. Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania. Clin Immunol 2005; 114: 256-265.
14. Green SJ, Meltzer MS, Hibbs JB Jr & Nacy CA. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 1990; 144: 278-283.
15. Mellor AL & Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-774.
16. Munn DH, Sharma MD & Mellor AL. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2, 3-dioxygenase activity in dendritic cells. J Immunol 2004; 172: 4100-4110.
17. Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002; 9: 1069-1077.
18. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U & Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase. J Exp Med 2002; 196: 459-468.
19. Frumento G, Rotondo R, Tonetti M & Ferrara GB. T cell proliferation is blocked by indoleamine 2, 3-dioxygenase. Transplant Proc 2001; 33: 428-430.
20. Terness P, Bauer TM, Rose L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002; 196: 447-457.
21. Sibley LD, Messina M & Niesman IR. Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proc Natl Acad Sci U S A 1994; 91: 5508-5512.
22. Mackenzie CR, Willberg CB & Daubener W. Inhibition of group B streptococcal growth by IFN gamma-activated human glioblastoma cells. J Neuroimmunol 1998; 89: 191-197.
23. MacKenzie CR, Hadding U & Daubener W. Interferon-gamma-induced activation of indoleamine 2, 3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J Infect Dis 1998; 178: 875-878.
24. Boasso A, Herbeuval JP, Hardy AW, et al. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2, 3-dioxygenase in plasmacytoid dendritic cells. Blood 2007; 109: 3351-3359.
25. van der Sluijs KF, Nijhuis M, Levels JH, et al. Influenza-induced expression of indoleamine 2, 3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis 2006; 193: 214-222.
26. Larrea E, Riezu-Boj JI, Gil-Guerrero L, et al. Upregulation of indoleamine 2, 3-dioxygenase in hepatitis C virus infection. J Virol 2007; 81: 3662-3666.
27. Tetsutani K, To H, Torii M, Hisaeda H & Himeno K. Malaria parasite induces tryptophan-related immune suppression in mice. Parasitology 2007; 134 (Pt 7): 923-930.
28. Makala LH, Baban B, Lemos H, et al. Leishmania major attenuates host immunity by stimulating local indoleamine 2, 3-dioxygenase expression. J Infect Dis [Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural]. 2011; 203: 715-725.
29. McDowell MA, Marovich M, Lira R, Braun M & Sacks D. Leishmania priming of human dendritic cells for CD40 Ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect Immun 2002; 70: 3994-4001.
30. Spath GF & Beverley SM. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 2001; 99: 97-103.
31. Trager W & Jensen JB. Human malaria parasites in continuous culture. Science (New York, NY) 1976; 193: 673-675.
32. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A & Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999; 189: 1363-1372.
33. Donovan MJ, Messmore AS, Scrafford DA, Sacks DL, Kamhawi S & McDowell MA. Uninfected mosquito bites confer protection against infection with malaria parasites. Infect Immun 2007; 75: 2523-2530.
34. Yadav M, Clark L & Schorey JS. Macrophage's proinflammatory response to a mycobacterial infection is dependent on sphingosine kinase-mediated activation of phosphatidylinositol phospholipase C, protein kinase C, ERK1/2, and phosphatidylinositol 3-kinase. J Immunol 2006; 176: 5494-5503.
35. Chaussabel D, Tolouei Semnani R, McDowell MA, Sacks D, Sher A & Nutman TB. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 2003; 102: 672-681.
36. Mahanonda R, Sa-Ard-Iam N, Montreekachon P, et al. IL-8 and IDO expression by human gingival fibroblasts via TLRs. J Immunol 2007; 178: 1151-1157.
37. Becker I, Salaiza N, Aguirre M, et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol 2003; 130: 65-74.
38. Flandin JF, Chano F & Descoteaux A. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Eur J Immunol 2006; 36: 411-420.
39. Kropf P, Freudenberg MA, Modolell M, et al. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect Immun 2004; 72: 1920-1928.
40. Puccetti P. On watching the watchers: IDO and type I/II IFN. Eur J Immunol 2007; 37: 876-879.
41. Jayakumar A, Donovan MJ, Tripathi V, Ramalho-Ortigao M & McDowell MA. Leishmania major infection activates NF-kappaB and interferon regulatory factors 1 and 8 in human dendritic cells. Infect Immun 2008; 76: 2138-2148.
42. Myint AM, Schwarz MJ, Steinbusch HW & Leonard BE. Neuropsychiatric disorders related to interferon and interleukins treatment. Metab Brain Dis [Review]. 2009; 24: 55-68.
43. Nagai T, Devergne O, van Seventer GA & van Seventer JM. Interferon-beta mediates opposing effects on interferon-gamma-dependent Interleukin-12 p70 secretion by human monocyte-derived dendritic cells. Scand J Immunol [Research Support, N.I.H., Extramural]. 2007; 65: 107-117.
44. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol [Review]. 2003; 3: 133-146.
45. Wang B, Koga K, Osuga Y, et al. Toll-like receptor-3 ligation-induced indoleamine 2, 3-dioxygenase expression in human trophoblasts. Endocrinology 2011; 152: 4984-4992.
46. Fallarino F, Vacca C, Orabona C, et al. Functional expression of indoleamine 2, 3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int Immunol 2002; 14: 65-68.
47. Hou DY, Muller AJ, Sharma MD, et al. Inhibition of indoleamine 2, 3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]. 2007; 67: 792-801.
48. Marovich MA, McDowell MA, Thomas EK & Nutman TB. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J Immunol 2000; 164: 5858-5865.
49. Carvalho EM, Teixeira RS & Johnson WD Jr. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun 1981; 33: 498-500.
50. Nickol AD & Bonventre PF. Immunosuppression associated with visceral leishmaniasis of hamsters. Parasite Immunol 1985; 7: 439-449.
51. Robinson TM, Nelson R, Artis D, Scott P & Boyer JD. Experimental Leishmania major infection suppresses HIV-1 DNA vaccine induced cellular immune response. Cells Tissues Organs 2004; 177: 185-188.
52. Toledo AC Jr & de Castro MR. Pneumocystis carinii pneumonia, pulmonary tuberculosis and visceral leishmaniasis in an adult HIV negative patient. Braz J Infect Dis 2001; 5: 154-157.
53. Gomes NA, Barreto-de-Souza V, Wilson ME & DosReis GA. Unresponsive CD4+ T lymphocytes from Leishmania chagasi-infected mice increase cytokine production and mediate parasite killing after blockade of B7-1/CTLA-4 molecular pathway. J Infect Dis 1998; 178: 1847-1851.